carbidopa and Parkinsonian Disorders

carbidopa has been researched along with Parkinsonian Disorders in 44 studies

Research

Studies (44)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (2.27)	18.2507
2000's	23 (52.27)	29.6817
2010's	16 (36.36)	24.3611
2020's	4 (9.09)	2.80

Authors

Authors	Studies
Bergman, H; Deffains, M; Eitan, R; Fonar, G; Iskhakova, L; Israel, Z; Marmor, O; Paz, R; Rappel, P	1
Cubo, E; Miranda, J	1
Ayala, A; Forjaz, MJ; Harmat, M; Janszky, J; Juhász, A; Kovács, N; Martinez-Martin, P; Pintér, D; Rodriguez-Blazquez, C	1
Honsberger, S; Husnain, MG; Su, JS	1
Angrisano, S; Cicolin, A; Lopiano, L; Merola, A; Montanaro, E; Priano, L; Romagnolo, A; Tribolo, A; Zibetti, M	1
Alhadhrami, A; Alharthi, SS; Alrobaian, MM; Kabel, AM; Omar, MS	1
Ikram, R; Riaz, B; Sikandar, B	1
Hamed, M; Lazarescu, A; Shetty, A; Suchowersky, O; Tremain, G	1
Abd El Fattah, MA; Badawi, GA; El Sayed, MI; Zaki, HF	1
Chen, YC; Ho, PL; Huang, P; Teng, CH; Wu, CC	1
Angrisano, S; Artusi, CA; Cocito, D; Lopiano, L; Merola, A; Rizzone, MG; Troiano, M; Zibetti, M	1
Farag, NE; Hammad, LN; Zaitone, SA	1
Chen, CH; Chen, NF; Chen, WF; Feng, CW; Hsiao, CD; Huang, SY; Hung, HC; Wang, HM; Wen, ZH; Yang, SN	1
Limón, ID; Palafox-Sánchez, V; Ramírez-García, G	1
Garg, A; Jha, S; Khanna, A	1
Hattori, N; Ishiguro, Y; Kawajiri, S; Noda, K; Okuma, Y; Tomizawa, Y; Tosaka, Y	1
Burgess, T; Cunningham, V; Glamuzina, E; Hill, R; Jacobsen, JC; Lehnert, K; Love, DR; Prosser, DO; Robertson, SP; Snell, RG; Swan, B; Taylor, J; Wilson, C	1
Khatoon, H; Mirza, T; Najam, R; Sikandar, B	1
Lima, MA; Maradei, S; Maranhao Filho, P	1
Alp, R; Alp, SI; Ure, H	1
Ahlskog, JE; Josephs, KA; Kumar, N; Matsumoto, JY; McKeon, A; Savica, R	1
Camargos, S; Cardoso, F; Lees, AJ; Singleton, A	1
Bar-Gad, I; Bergman, H; Goldberg, JA; Heimer, G	1
Hirsch, EC; Muriel, MP; Orieux, G	1
Minagar, A; Shulman, LM; Weiner, WJ	1
Hansard, MJ; Jackson, MJ; Jenner, P; Maratos, E; Smith, LA	1
Cheetham, SC; Hansard, MJ; Jackson, MJ; Jenner, P; Smith, LA	1
Bruno, MK; Considine, E; Garraux, G; Gwinn-Hardy, K; Hallett, M; Hanson, M; Johnson, J; Ptacek, L; Ravina, B; Singleton, A	1
Chen, CM; Lee-Chen, GJ; Tang, LM; Wang, CK; Wang, SC; Wu, YR	1
Vieregge, P	1
Antenor, J; Black, KJ; Burkey, A; Esper, GJ; Kotagal, V; Moerlein, SM; Ojemann, JG; Perlmutter, JS; Racette, BA; Videen, TO	1
Akalan, N; Arica, B; Hincal, AA; Kaş, HS; Moghdam, A	1
Alvarez, L; Castro, A; Gimenez-Roldan, S; Grandas, F; Hernandez, B; Jenner, P; Linazasoro, G; Luquin, MR; Macias, R; Marin, C; Obeso, JA; Pavon, N; Rodriguez, M; Rodriguez-Oroz, MC; Stochi, F; Tolosa, E; Vaamonde, J; Valldeoriola, F	1
Obara, K; Ohta, K	1
Berry-Kravis, E; Hagerman, PJ; Hagerman, RJ; Hall, DA; Leehey, MA; Rice, CD	1
Bain, PG; Hensman, DJ	1
Kanzato, N; Murao, H; Nishihira, T; Takara, H	1
Mosekilde, L; Rejnmark, L; Vestergaard, P	1
Desimone, R; Fiorani, M; Oldfield, EH; Papa, SM	1
Brusa, L; Gasparini, M; Meco, G; Vanacore, N	1
Hara, A; Matsushita, S; Mita, S; Murakami, T; Nakajima, M; Nakamura, T; Uchino, M; Uyama, E	1
Gerlach, M; Kuhn, W; Lehnfeld, R; Riederer, P; Sontag, KH; Waldmeier, P; Xiao, AY	1
Abe, K; Miyatake, T; Ren, J; Sano, T; Shinohara, T; Taguchi, K; Utsunomiya, I; Wasai, T	1
Campos, V; García De Yébenes, J; Mena, MA; Meseguer, E; Sánchez, V; Taboada, R	1

Reviews

2 review(s) available for carbidopa and Parkinsonian Disorders

Article	Year
[Optimization of use of levodopa in Parkinson's disease: role of levodopa-carbidopa-entacapone combination]. Neurologia (Barcelona, Spain), 2005, Volume: 20, Issue:4 Topics: Akathisia, Drug-Induced; Animals; Antiparkinson Agents; Carbidopa; Catechols; Clinical Trials as Topic; Dopamine; Drug Therapy, Combination; Humans; Hyperhomocysteinemia; Levodopa; MPTP Poisoning; Neuroprotective Agents; Nitriles; Parkinson Disease; Parkinsonian Disorders; Rats; Treatment Outcome	2005
Parkinsonian symptoms as an initial manifestation in a Japanese patient with acquired immunodeficiency syndrome and Toxoplasma infection. Internal medicine (Tokyo, Japan), 2000, Volume: 39, Issue:12 Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Carbidopa; Corpus Striatum; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parietal Lobe; Parkinsonian Disorders; Pyrimethamine; Syphilis; Toxoplasmosis, Cerebral	2000

Article

Year

[Optimization of use of levodopa in Parkinson's disease: role of levodopa-carbidopa-entacapone combination].

Neurologia (Barcelona, Spain), 2005, Volume: 20, Issue:4

Topics: Akathisia, Drug-Induced; Animals; Antiparkinson Agents; Carbidopa; Catechols; Clinical Trials as Topic; Dopamine; Drug Therapy, Combination; Humans; Hyperhomocysteinemia; Levodopa; MPTP Poisoning; Neuroprotective Agents; Nitriles; Parkinson Disease; Parkinsonian Disorders; Rats; Treatment Outcome

2005

Parkinsonian symptoms as an initial manifestation in a Japanese patient with acquired immunodeficiency syndrome and Toxoplasma infection.

Internal medicine (Tokyo, Japan), 2000, Volume: 39, Issue:12

Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Carbidopa; Corpus Striatum; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parietal Lobe; Parkinsonian Disorders; Pyrimethamine; Syphilis; Toxoplasmosis, Cerebral

2000

Trials

1 trial(s) available for carbidopa and Parkinsonian Disorders

Article	Year
Prospective assessment of peripheral neuropathy in Duodopa-treated parkinsonian patients. Acta neurologica Scandinavica, 2014, Volume: 129, Issue:1 Topics: Action Potentials; Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Follow-Up Studies; Gels; Humans; Intestinal Absorption; Levodopa; Male; Middle Aged; Neural Conduction; Parkinsonian Disorders; Peripheral Nervous System Diseases; Prospective Studies; Reaction Time; Vitamin B 12; Vitamin B 12 Deficiency	2014

Article

Year

Prospective assessment of peripheral neuropathy in Duodopa-treated parkinsonian patients.

Acta neurologica Scandinavica, 2014, Volume: 129, Issue:1

Topics: Action Potentials; Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Follow-Up Studies; Gels; Humans; Intestinal Absorption; Levodopa; Male; Middle Aged; Neural Conduction; Parkinsonian Disorders; Peripheral Nervous System Diseases; Prospective Studies; Reaction Time; Vitamin B 12; Vitamin B 12 Deficiency

2014

Other Studies

41 other study(ies) available for carbidopa and Parkinsonian Disorders

Article	Year
Modulation of dopamine tone induces frequency shifts in cortico-basal ganglia beta oscillations. Nature communications, 2021, 12-02, Volume: 12, Issue:1 Topics: Action Potentials; Animals; Basal Ganglia; Beta Rhythm; Carbidopa; Cerebral Cortex; Chlorocebus aethiops; Dopamine; Electrodes, Implanted; Eye-Tracking Technology; Female; Humans; Levodopa; Magnetic Resonance Imaging; Nerve Net; Organic Chemicals; Parkinson Disease; Parkinsonian Disorders; Pupil; Stereotaxic Techniques	2021
Spinocerebellar ataxia type 3: response to levodopa infusion in two cases. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022, Volume: 43, Issue:5 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Gels; Humans; Infusions, Parenteral; Levodopa; Machado-Joseph Disease; Neurodegenerative Diseases; Parkinson Disease; Parkinsonian Disorders	2022
Which Scale Best Detects Treatment Response of Tremor in Parkinsonism? Journal of Parkinson's disease, 2020, Volume: 10, Issue:1 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Deep Brain Stimulation; Drug Combinations; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Outcome Assessment, Health Care; Parkinsonian Disorders; Sensitivity and Specificity; Severity of Illness Index; Tremor	2020
Transient parkinsonism associated with acute Legionnaires' disease. BMJ case reports, 2020, Jan-07, Volume: 13, Issue:1 Topics: Adult; Anti-Bacterial Agents; Antiparkinson Agents; Carbidopa; Ciprofloxacin; Drug Combinations; Drug Therapy, Combination; Dysarthria; Humans; Legionella; Legionnaires' Disease; Levodopa; Male; Parkinsonian Disorders; Respiratory Insufficiency	2020
A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion. Journal of neurology, 2017, Volume: 264, Issue:6 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gels; Humans; Intestines; Levodopa; Male; Mental Status and Dementia Tests; Middle Aged; Parkinsonian Disorders; Polysomnography; Severity of Illness Index; Sleep Wake Disorders; Statistics, Nonparametric; Surveys and Questionnaires; Treatment Outcome	2017
Linagliptin potentiates the effect of l-dopa on the behavioural, biochemical and immunohistochemical changes in experimentally-induced Parkinsonism: Role of toll-like receptor 4, TGF-β1, NF-κB and glucagon-like peptide 1. Physiology & behavior, 2018, 05-01, Volume: 188 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Carbidopa; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Glucagon-Like Peptide 1; Levodopa; Linagliptin; Mice; Mice, Inbred BALB C; NF-kappa B; Parkinsonian Disorders; Toll-Like Receptor 4; Transforming Growth Factor beta1	2018
Anticataleptic activity of Zamzam water in chlorpromazine induced animal model of Parkinson disease. Pakistan journal of pharmaceutical sciences, 2018, Volume: 31, Issue:2 Topics: Animals; Brain; Carbidopa; Catalepsy; Chlorpromazine; Disease Models, Animal; Drug Combinations; Hydrogen-Ion Concentration; Levodopa; Parkinsonian Disorders; Rats; Water	2018
A case of Perry Syndrome responding to intestinal infusion of carbidopa/levodopa. Parkinsonism & related disorders, 2019, Volume: 61 Topics: Antiparkinson Agents; Carbidopa; Depression; Drug Combinations; Female; Gels; Humans; Hypoventilation; Infusions, Parenteral; Jejunostomy; Levodopa; Middle Aged; Parkinsonian Disorders	2019
Sitagliptin and Liraglutide Modulate L-dopa Effect and Attenuate Dyskinetic Movements in Rotenone-Lesioned Rats. Neurotoxicity research, 2019, Volume: 35, Issue:3 Topics: Animals; Antiparkinson Agents; Carbidopa; Corpus Striatum; Dopamine; Drug Combinations; Dyskinesia, Drug-Induced; Levodopa; Liraglutide; Male; Motor Activity; Parkinsonian Disorders; Pars Compacta; Random Allocation; Rats, Wistar; Rotenone; Sitagliptin Phosphate	2019
Acute parkinsonism as an unexpected consequence of pituitary adenoma resection: A case report. Medicine, 2019, Volume: 98, Issue:17 Topics: Adenoma; Adult; Carbidopa; Drug Combinations; Female; Humans; Hyponatremia; Levodopa; Magnetic Resonance Imaging; Myelinolysis, Central Pontine; Parkinsonian Disorders; Pituitary Neoplasms	2019
Antioxidant potential of melatonin enhances the response to L-dopa in 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine-parkinsonian mice. Pharmacological reports : PR, 2013, Volume: 65, Issue:5 Topics: Animals; Antioxidants; Antiparkinson Agents; Basal Ganglia; Behavior, Animal; Carbidopa; Catalase; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Glutathione; Glutathione Peroxidase; Levodopa; Lipid Peroxidation; Male; Malondialdehyde; Melatonin; Mice; Motor Activity; Oxidative Stress; Parkinsonian Disorders; Superoxide Dismutase	2013
Effects of 6-hydroxydopamine exposure on motor activity and biochemical expression in zebrafish (Danio rerio) larvae. Zebrafish, 2014, Volume: 11, Issue:3 Topics: Animals; Antiparkinson Agents; Anxiety; Biomarkers; Blotting, Western; Carbidopa; Disease Models, Animal; Drug Combinations; Levodopa; Minocycline; Motor Activity; Oxidopamine; Parkinsonian Disorders; Real-Time Polymerase Chain Reaction; Sympatholytics; Vitamin E; Zebrafish; Zebrafish Proteins	2014
Nitrosative and cognitive effects of chronic L-DOPA administration in rats with intra-nigral 6-OHDA lesion. Neuroscience, 2015, Apr-02, Volume: 290 Topics: Animals; Antiparkinson Agents; Astrocytes; Carbidopa; Corpus Striatum; Gliosis; Levodopa; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Oxidopamine; Parkinsonian Disorders; Pars Compacta; Prefrontal Cortex; Rats, Wistar; Spatial Memory	2015
Dissociative disorder manifesting for underlying adolescent hemi-parkinsonism: New chronology for old mummies. Asian journal of psychiatry, 2015, Volume: 16 Topics: Adult; Age of Onset; Antiparkinson Agents; Carbidopa; Dissociative Disorders; Drug Combinations; Female; Humans; Levodopa; Parkinsonian Disorders; Young Adult	2015
Delayed chorea after recovery from severe akinetic-rigid parkinsonism caused by extrapontine myelinolysis. Journal of the neurological sciences, 2015, Nov-15, Volume: 358, Issue:1-2 Topics: Carbidopa; Chorea; Disease Progression; Dopamine Agonists; Drug Combinations; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Muscle Rigidity; Myelinolysis, Central Pontine; Parkinsonian Disorders	2015
Brain dopamine-serotonin vesicular transport disease presenting as a severe infantile hypotonic parkinsonian disorder. Journal of inherited metabolic disease, 2016, Volume: 39, Issue:2 Topics: Brain; Brain Diseases; Carbidopa; Child; Dopamine; Humans; Levodopa; Male; Parkinsonian Disorders; Polymorphism, Single Nucleotide; Serotonin	2016
Beneficial anti-Parkinson effects of camel milk in Chlorpromazineinduced animal model: Behavioural and histopathological study. Pakistan journal of pharmaceutical sciences, 2016, Volume: 29, Issue:5 Topics: Animals; Antiparkinson Agents; Behavior, Animal; Brain; Camelus; Carbidopa; Catalepsy; Chlorpromazine; Drug Combinations; Female; Levodopa; Male; Milk; Parkinsonian Disorders; Rats, Wistar; Time Factors	2016
Cyclosporine-induced parkinsonism. Journal of neurology, 2009, Volume: 256, Issue:4 Topics: Antiparkinson Agents; Brain; Carbidopa; Cyclosporine; Fatal Outcome; Hematoma, Subdural; Humans; Immunosuppressive Agents; Leukemia, Lymphoid; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parkinsonian Disorders; Stem Cell Transplantation	2009
Cavernous hemangioma: a rare cause for secondary parkinsonism: a case report. The International journal of neuroscience, 2009, Volume: 119, Issue:11 Topics: Aged; Antiparkinson Agents; Basal Ganglia Diseases; Carbidopa; Female; Globus Pallidus; Hemangioma, Cavernous, Central Nervous System; Humans; Levodopa; Magnetic Resonance Imaging; Parkinsonian Disorders; Putamen; Tomography, X-Ray Computed; Treatment Failure	2009
Parkinsonism and dropped head: dystonia, myopathy or both? Parkinsonism & related disorders, 2012, Volume: 18, Issue:1 Topics: Aged; Carbidopa; Drug Combinations; Dystonic Disorders; Electromyography; Female; Head Movements; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Muscular Diseases; Parkinsonian Disorders; Retrospective Studies	2012
DYT16: the original cases. Journal of neurology, neurosurgery, and psychiatry, 2012, Volume: 83, Issue:10 Topics: Adolescent; Adult; Age of Onset; Anti-Dyskinesia Agents; Antiparkinson Agents; Baclofen; Biperiden; Botulinum Toxins; Carbidopa; Child; Child, Preschool; Cholinergic Antagonists; Drug Combinations; Drug Resistance; Dystonia; Dystonic Disorders; Female; Humans; Levodopa; Male; Middle Aged; Muscle Relaxants, Central; Mutation; Parkinsonian Disorders; Pedigree; Phenotype; RNA-Binding Proteins; Speech Disorders; Trihexyphenidyl; Young Adult	2012
Dopamine replacement therapy reverses abnormal synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of parkinsonism. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002, Sep-15, Volume: 22, Issue:18 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Action Potentials; Animals; Antiparkinson Agents; Bromocriptine; Carbidopa; Chlorocebus aethiops; Disease Models, Animal; Dopamine; Dopamine Agonists; Drug Therapy, Combination; Electrodes, Implanted; Female; Globus Pallidus; Levodopa; Neurons; Organic Chemicals; Parkinsonian Disorders	2002
Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in parkinsonian rats. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:6 Topics: Animals; Antiparkinson Agents; Carbidopa; Corpus Striatum; Cytoplasm; Drug Combinations; Indoles; Levodopa; Male; Microscopy, Immunoelectron; Neurons; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Synaptic Membranes; Tyrosine 3-Monooxygenase	2002
Reversal of parkinsonism following liver transplantation. Neurology, 2003, Feb-11, Volume: 60, Issue:3 Topics: Acute Disease; Aged; Antiparkinson Agents; Carbidopa; Disease Progression; Gait Disorders, Neurologic; Humans; Immunosuppressive Agents; Levodopa; Liver Cirrhosis; Liver Transplantation; Male; Parkinsonian Disorders; Remission Induction; Treatment Outcome; Tremor	2003
Effect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: effect of dose, frequency of administration, and brain exposure. Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:5 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Callithrix; Carbidopa; Catechols; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Levodopa; Locomotion; Male; Nitriles; Parkinsonian Disorders; Pulse Therapy, Drug; Substantia Nigra; Time Factors	2003
The monoamine reuptake inhibitor BTS 74 398 fails to evoke established dyskinesia but does not synergise with levodopa in MPTP-treated primates. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:1 Topics: Animals; Antiparkinson Agents; Callithrix; Carbidopa; Chlorobenzenes; Cyclobutanes; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Dyskinesia, Drug-Induced; Levodopa; Locomotion; Male; Motor Activity; Motor Skills; Neurologic Examination; Parkinsonian Disorders; Postural Balance; Stereotyped Behavior	2004
Exercise-induced dystonia as a preceding symptom of familial Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:2 Topics: Aged; Antiparkinson Agents; Carbidopa; Disease Progression; DNA Mutational Analysis; Drug Combinations; Dystonic Disorders; Exercise; Female; Genotype; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinsonian Disorders; Phenotype; Semen; Ubiquitin-Protein Ligases; Videotape Recording	2004
Markedly asymmetrical parkinsonism as a leading feature of adult-onset Huntington's disease. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:7 Topics: Adult; Alleles; Antiparkinson Agents; Carbidopa; Cognition Disorders; Diagnosis, Differential; Drug Combinations; Humans; Huntington Disease; Levodopa; Male; Neuropsychological Tests; Parkinsonian Disorders; Pedigree; Severity of Illness Index	2004
[Diagnosis and treatment of parkinsonian syndrome]. MMW Fortschritte der Medizin, 2004, May-24, Volume: 146 Spec No 2 Topics: Antiparkinson Agents; Carbidopa; Combined Modality Therapy; Diagnosis, Differential; Humans; Neurologic Examination; Occupational Therapy; Parkinsonian Disorders; Physical Therapy Modalities	2004
Pathophysiology of parkinsonism due to hydrocephalus. Journal of neurology, neurosurgery, and psychiatry, 2004, Volume: 75, Issue:11 Topics: Adult; Antiparkinson Agents; Brain Mapping; Carbidopa; Caudate Nucleus; Cerebral Ventricles; Drug Combinations; Equipment Failure; Humans; Hydrocephalus; Hypokinesia; Levodopa; Magnetic Resonance Imaging; Male; Neurologic Examination; Parkinsonian Disorders; Positron-Emission Tomography; Postoperative Complications; Putamen; Ventriculoperitoneal Shunt	2004
Carbidopa/levodopa-loaded biodegradable microspheres: in vivo evaluation on experimental Parkinsonism in rats. Journal of controlled release : official journal of the Controlled Release Society, 2005, Feb-16, Volume: 102, Issue:3 Topics: Animals; Biotransformation; Carbidopa; Drug Evaluation, Preclinical; Levodopa; Male; Microspheres; Parkinsonian Disorders; Rats	2005
Hemiparkinsonism with a discrete lacunar infarction in the contralateral substantia nigra. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:1 Topics: Antiparkinson Agents; Brain Stem Infarctions; Carbidopa; Cerebral Infarction; Diagnosis, Differential; Dominance, Cerebral; Drug Therapy, Combination; Follow-Up Studies; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Neurologic Examination; Parkinsonian Disorders; Substantia Nigra; Tomography, Emission-Computed, Single-Photon	2006
Symptomatic treatment in the fragile X-associated tremor/ataxia syndrome. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:10 Topics: Adrenergic beta-Antagonists; Aged; Anxiety Disorders; Benzodiazepines; Carbidopa; Central Nervous System Agents; Cerebellar Ataxia; Cholinesterase Inhibitors; Dopamine Agonists; Female; Fragile X Syndrome; Humans; Levodopa; Male; Memory Disorders; Middle Aged; Neurologic Examination; Parkinsonian Disorders; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Tremor	2006
Levodopa can worsen tremor associated with dystonia. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:10 Topics: Aged; Antiparkinson Agents; Carbidopa; Diagnostic Errors; Drug Combinations; Dystonia; Female; Humans; Levodopa; Neurologic Examination; Parkinsonian Disorders; Psychomotor Performance; Tremor	2006
[Case of juvenile parkinsonism in pregnancy]. Rinsho shinkeigaku = Clinical neurology, 2006, Volume: 46, Issue:6 Topics: Adult; Antiparkinson Agents; Benzothiazoles; Cabergoline; Carbidopa; Contraindications; Dopamine Agents; Dopamine Agonists; Ergolines; Family Planning Services; Female; Humans; Infant, Newborn; Levodopa; Parkinsonian Disorders; Pramipexole; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Thiazoles	2006
Fracture risk associated with parkinsonism and anti-Parkinson drugs. Calcified tissue international, 2007, Volume: 81, Issue:3 Topics: Adult; Age Factors; Antiparkinson Agents; Carbidopa; Case-Control Studies; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Enzyme Inhibitors; Female; Fractures, Bone; Humans; Levodopa; Male; Monoamine Oxidase Inhibitors; Parkinsonian Disorders; Risk Factors; Sex Factors; Time Factors	2007
Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias. Annals of neurology, 1999, Volume: 46, Issue:5 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Carbidopa; Drug Combinations; Dyskinesia, Drug-Induced; Dyskinesias; Electrophysiology; Eye Movements; Globus Pallidus; Levodopa; Macaca mulatta; Motor Activity; Neurons; Parkinsonian Disorders	1999
A possible association between exposure to n-hexane and parkinsonism. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2000, Volume: 21, Issue:1 Topics: Antiparkinson Agents; Carbidopa; Drug Therapy, Combination; Electromyography; Evoked Potentials, Auditory, Brain Stem; Evoked Potentials, Somatosensory; Hexanes; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Occupational Diseases; Parkinsonian Disorders; Selegiline; Solvents	2000
The central catechol-O-methyltransferase inhibitor tolcapone increases striatal hydroxyl radical production in L-DOPA/carbidopa treated rats. Journal of neural transmission (Vienna, Austria : 1996), 2001, Volume: 108, Issue:2 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Hydroxyl Radical; Levodopa; Male; Microdialysis; Nitriles; Nitrophenols; Oxidative Stress; Parkinsonian Disorders; Rats; Rats, Wistar; Tolcapone	2001
Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4-tetrahydroisoquinolines on a mouse model of Parkinson's disease. Brain research bulletin, 2001, Sep-01, Volume: 56, Issue:1 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Carbidopa; Cell Count; Disease Models, Animal; Dopamine; Dopamine Antagonists; Drug Interactions; Homovanillic Acid; Hydroxyindoleacetic Acid; Hypokinesia; Immunohistochemistry; Isoquinolines; Levodopa; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Neurotoxins; Parkinsonian Disorders; Serotonin; Stereoisomerism; Substantia Nigra; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase	2001
Life-threatening parkinsonism induced by kava-kava. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:1 Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Humans; Kava; Levodopa; Middle Aged; Parkinsonian Disorders; Tremor	2002